SGS has invested in a new Genotypic DNA sequencing MicroSeq Rapid Microbial Identification System from Applied Biosystems at its Chicago facility. The molecular identification system is undergoing validation and is expected to be fully implemented in 3Q16 to provide high speed microbiological testing for the identification of microorganisms.   According to the FDA’s 2004 guidance, “Sterile Drug Products Produced by Aseptic Processing – Current Good Manufacturing Practice,” genotypic methods ha...